What is Love?

What is Love?

Love is not a "once and for all" heaven sent situation.
Rather, LOVE is more of an intentional and 
dynamic spiritual exercise of 
opening oneself up to the OTHER
who HAS LOVED us first.
This journey involves 
a lifelong process of deepening our capability
 to exhaust the endless ways of expressing LOVE, 
most especially when we are challenged and are already spent.

Love is a practice of "holding someone in the light"

by visualizing someone 

in the circle of God's love and presence 

defending your life. 

 Quakers

Creativity

Creation, on the human level, does not come from nothing.  Human creation has something to do the with the production of something that is new and different from what the subject has originally been created for.  We all know that only God can "create something out of nothing," as St. Thomas Aquinas has reminded us. We humans, on the other hand, can be God's co-creator, as we are all born with the creative and dynamic potentials as created beings made in the image of God. 

 I believe that in all of us, there is this God given gift of innate creativity.  I may not have enough
time, talent and resources like some gifted artists.  But I wonder how creative we all can be if we would be imaginative and expressive enough to capture the inexhaustible beauty around us. 

  May we all live inspired and always in awe and wonder!

Has your health facility been consistent in requiring PCP's with your patient's latest laboratory results prior to giving them their Reclast Infusion? Here's the latest FDA warning to Physicians to ensure your patients' safety:

FDA Warns Physicians To Test Kidney Function Before Prescribing Reclast.

The Wall Street Journal /Dow Jones Newswires (9/2, Dooren, Subscription Publication) reports that the Food and Drug Administration has updated a warning regarding kidney failure and use of Novartis' Reclast (zoledronic acid). The FDA said that kidney failure "was a rare but serious condition associated with the use of Reclast in patients with a history of or risk factors for [kidney] impairment." Physicians are being warned, therefore, to check patient kidney function before prescribing Reclast and to check those who are already taking the drug.

        MedPage Today (9/2, Gever) says, "The new warning indicates that patients with creatinine clearance of less than 35 mL/min or evidence of acute renal impairment should not be given zoledronic acid for osteoporosis." The warning also lists risk factors including "advanced age, concurrent treatment with other nephrotoxic drugs, and dehydration secondary to fever, sepsis, gastrointestinal losses, or diuretic therapy."

Countering Conflict in the Workplace

How do you manage conflicts in the Workplace in the healthcare setting? Here's an excerpt on this topic from the NurseTogether.com Community members’ online chat on "Countering Conflict in the Workplace" with Dr. Catherine Garner. Dr. Garner is the Dean of Health Sciences and Nursing at the American Sentinel University.Countering Conflict in the Workplace